openPR Logo
Press release

RenewSense Enters Brainnovation, Israel's Brain Technologies Accelerator

07-18-2016 12:47 PM CET | Science & Education

Press release from: Yissum

RenewSense Enters Brainnovation, Israel's Brain Technologies

Yissum Research Development Company Ltd., the technology transfer arm of the Hebrew University of Jerusalem, today announced that RenewSense was selected to enter Brainnovation, Israel's Brain Technologies accelerator.

"A truly remarkable technology that could change the quality of life for so many blind people in the world" says Tamir Huberman.

RenewSenses, based on research from the lab of Professor Amir Amedi, from the Department of Medical Neurobiology at the Hebrew University of Jerusalem and the Edmond & Lily Safra Center for Brain Science, develops devices that can aid the blind and visually-disabled to navigate using other senses like sound and touch. One such device is the EyeCane, a small flashlight-like device which uses components that translate distance into sound and vibrations. The device translates the distance to a target into a corresponding frequency of auditory and tactile cues, enabling the user "to feel" the world around her or him within a range of up to five meters. The EyeCane can augment a white cane with further distance and wider angles, protecting from high obstacles, and offers a non-obtrusive way to explore one's environment. After only five minutes of training users can estimate distances, avoid obstacles and successfully navigate in simple environments.

Another product is EyeMusic, which uses musical notes to convey information on any given scene, colors, shapes and location of objects. Users wear a miniature camera connected to a smartphone or small computer and stereo headphones. The images are converted into "soundscapes" using an algorithm, allowing the user to listen and then interpret the visual information coming from the image. After training, blind individuals can recognize the letters of the alphabet, "see" pictures of animals, and even find an object-such as a pair of shoes or a person-in a complex visual landscape. A new version of this device is available free of charge on the Apple App Store and Google Play, offering significant new advantages such as an inbuilt self-training program and games.

"Amazing research is currently being conducted at Prof. Amedi's Lab for Brain and Multisensory Research. The group studies the brain activity of blind people and challenges conventional wisdom by which the brain is divided into distinct regions mainly by the sensory input. They demonstrate that people have the ability to take information from one sense and present it in another, thus enabling blind people to "see" by using other senses such as touching or hearing," stated Yaacov Michlin, CEO of Yissum. "Joining Brainnovation will assist RenewSenses to swiftly bring the devices developed based on this understanding, EyeCane and EyeMusic, to the visually impaired community."

"Our mission is to provide a true solution for the blind and visually impaired, based on the natural brain function that utilizes other senses like hearing and touching in order to compensate for the loss of vision," said Daphna Rosenbaum, Managing Director, RenewSenses. "The Brainnovation program is a great opportunity for RenewSenses to gain knowledge and guidance on how to succeed in the braintech ecosystem".

Tamir Huberman is VP Business Development at Yissum in the field of Computer Science which is responsible for licensing this technology.

Israel Brain Technologies (IBT) is a non-profit organization whose mission is to turn Israel into a global brain technology and research hub. Brainnovations is IBT's launchpad program promoting early stage startups. The program provides chosen startups with everything they need in order to build a successful venture in the brain space. The first group of eight braintech startups graduated from the program in February 2016. RenewSenses is one of the eight ventures that are now embarking on the second cycle of Brainnovations.

Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. was founded in 1964 to protect and commercialize the Hebrew University's intellectual property. Products based on Hebrew University technologies that have been commercialized by Yissum currently generate $2 Billion in annual sales. Ranked among the top technology transfer companies in the world, Yissum has registered over 9,325 patents covering 2,600 inventions; has licensed out 880 technologies and has spun out 110 companies including Mobileye, Briefcam, Orcam, Avraham Pharmaceuticals, Betalin Therapeutics, CollPlant and Qlight Nanotech. Yissum's business partners span the globe and include companies such as Microsoft, Intel, Johnson & Johnson, Novartis, Roche, Merck, Teva, Syngenta, Monsanto and many more. For further information please visit

Tamir Huberman
Hi-Tech Park, Givat Ram, PO BOX 39135
Jerusalem, Israel

This release was published on openPR.

Permanent link to this press release:

Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release RenewSense Enters Brainnovation, Israel's Brain Technologies Accelerator here

News-ID: 349668 • Views: 1188

More Releases from Yissum

Intel's $15 billion purchase of Mobileye shakes up driverless car sector
Intel's $15 billion purchase of Mobileye shakes up driverless car sector
Mobileye's technologies were originated at the Hebrew University of Jerusalem and Licensed to Mobileye by Yissum, the Technology Transfer arm of the University. Tamir Huberman is VP Business Development at Yissum which is reponsible for all the Computer Science Researchers at the University including Prof Amnon Shashua. By Tova Cohen, Ari Rabinovitch and Paul Lienert | JERUSALEM/DETROIT Intel Corp (INTC.O) agreed to buy Israeli autonomous vehicle technology firm Mobileye (MBLY.N) for
Home Instruction for Parents and Preschool Youngsters (HIPPY) Program to be Launched in Korea
Home Instruction for Parents and Preschool Youngsters (HIPPY) Program to be Laun …
JERUSALEM, March 8, 2017 Tamir Huberman is VP Business Development at Yissum responsible for licensing this program. Yissum Research Development Company of the Hebrew University of Jerusalem, the technology-transfer company of the Hebrew University, announced today that it has signed an agreement with Lolo Educational Services Co. (LES), Korea for the entrance of it its wholly-owned Home Instruction for Parents and Preschool Youngsters (HIPPY) program into Korea. HIPPY is an early learning program
Yissum Licenses Technology for Enhanced Digital Image Processing to Lightricks
Yissum Licenses Technology for Enhanced Digital Image Processing to Lightricks
JERUSALEM, June 14, 2016 /PRNewswire/ -- Yissum Research Development Company Ltd., the technology transfer arm of the Hebrew University of Jerusalem, today announced that it has signed a non-exclusive worldwide licensing agreement and a consulting agreement with Lightricks for the development and commercialization of an imaging technology that improves digital image processing. The technology, invented by Prof. Raanan Fattal from the School of Computer Science and Engineering at the Hebrew

All 4 Releases

More Releases for Brain

Retro X Focus Nootropic Brain Booster - SUPERCHARGED BRAIN PERFORMANCE!
Retro X Focus Nootropic Brain Booster is a state-of-the-art nootropic that employs vitamins, vital nutrients, plus amino acids to assist you to think quicker, cleverer, smarten your memory, and improve attention and leave you feeling invigorated. The water-soluble extracts, which are useful in product additives, function to rejuvenate studying approaches and thinking. Official Online Store - How does the Retro X Focus Function? It is common knowledge that we must work out
Cogni Brain 360 - Does It Really Work For Brain Health!
Cogni Brain 360 Some signs of cerebrum depression include mental and emotional upheavals and feelings that are not predictable. Many of these symptoms occur when your brain isn't in a stable state or not receiving the necessary supplements. Official Website: CLICK HERE=> Cogni Brain 360 - What is it? Cogni Brain 360This causes mental decrease in a normal setting and accelerates psychological rot. It can also cause severe and long-lasting mental damage
Brain Cancer Diagnostics Market: Increase in Prevalence of Brain Cancer Worldwid …
The scope of the brain cancer diagnostics market includes diagnostic type, cancer type, end user, and region. The brain cancer diagnostics market is analyzed based on regions such as North America, Europe, Asia Pacific, the Middle East & Africa, and South & Central America. The report offers insights and in-depth analysis of the brain cancer diagnostics market, emphasizing various parameters such as market trends, technological advancements, market dynamics, and competitive
Geehii Brain Pills Review-Does Geehii Brain Work-Complete Info
Your thoughts is what makes you who you're. It consists of your recollections, personality, and selection-making strategies. We need to inform you about a supplement known as Geehii Brain Pills. This is a method that aid mind fitness and help you reap your complete capacity. After all, you consume proper and workout to maintain your body wholesome, why wouldn’t you do something to make certain you mind remains as wholesome
Wireless Brain Sensors Market 2017- EMOTIV, Advanced Brain Monitoring, Muse, Neu …
Apex Market Reports, recently published a detailed market research study focused on the "Wireless Brain Sensors Market" across the global, regional and country level. The report provides 360° analysis of "Wireless Brain Sensors Market" from view of manufacturers, regions, product types and end industries. The research report analyses and provides the historical data along with current performance of the global Wireless Brain Sensors industry, and estimates the future trend of
4th International conference on Brain Disorders and Brain Injury
Dear Members, I hope you are doing well This is Karlin Zoe; we would like to invite at our upcoming 4th International Conference on Brain Disorder and Brain Injury on August 14-16, 2017 at Toronto, Canada Participate at this conference and earn up to 20 AMA PRA Category 1 Credits TM Mark your calendar as busy on August 14-16, 2017; they are the official dates for the Brain Injury 2017. Participation benefits: Claim CME